ovarian cancer

April 20, 2022

Study addresses living well after ovarian cancer

Patients in remission can experience high stress, fear of recurrence and ongoing side effects, an oncologist says. 

Read more
microscopic shot of ovarian cancer cells
January 18, 2022

Ovarian cancer is not a silent killer

Many women report symptoms early on, which are often dismissed by providers, according to one UW Medicine oncology expert.

Read more
photo of cancer cell
May 3, 2021

New drug class gives hope to some ovarian cancer patients

The study provides insights into how the cancers resist treatments, and which patients may benefit from treatment. 

Read more
illustrations suggesting DNA research
May 27, 2020

At-home screening for ovarian, breast cancers is effective

MAGENTA study also found no increased stress among test subjects who did not receive pre- and post-test counseling with their results. 

Read more
Dr. Swisher in her lab
May 26, 2020

Making genetic testing accessible for ovarian cancer

There is currently no way to detect ovarian cancer early. But genetic testing enables doctors to identify a person's risk and may help prevent the cancer.

DNA conceptual art
September 12, 2018

1,000s of breast cancer gene variants engineered, analyzed

Findings on nearly 4,000 BRCA1 mutations will be immediately useful to many patients with previously inconclusive genetic test results.

Read more
Genetic testing for ovarian cancer
August 21, 2018

MAGENTA test can screen for ovarian cancer

This KING5 video looks at a free home genetic test for women who are at risk for ovarian cancer is available through MAGENTA, which s short for MAking GENetic Testing Accessible

Read more
CA125 test for ovarian cancer
August 22, 2018

Unconscious bias plays role in ovarian cancer screenings

In patient referrals, primary care physicians are influenced by their own connections to the disease, study suggests.

Read more
picture of Elizabeth Swisher
August 17, 2018

Segment: Home genetic test for ovarian cancer

A free home genetic test for women who are at risk for ovarian cancer is available through MAGENTA, which s short for MAking GENetic Testing Accessible.

May 2, 2016

Cancer-like mutations prevalent in apparently healthy group

In a study of 36 women – 16 diagnosed with ovarian cancer and a control group of 20 with no cancer diagnosis – nearly all of the women were found to carry cancer-associated gene mutations.

Read more

Pages

Subscribe to ovarian cancer